http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-206473565-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_829938d5b855de58a479cd48cd72a489 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2016-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ede7c671563542f8d6858867c9b67056 |
| publicationDate | 2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-206473565-U |
| titleOfInvention | With the fragrant lotus oral disnitegration tablet of the high effect of reduction by three |
| abstract | The utility model provides a kind of with the fragrant lotus oral disnitegration tablets of the high effect of reduction by three, including the first lamellar body in a ring and the second rounded lamellar body, the external diameter of second lamellar body is less than the internal diameter of the first lamellar body, and the outer wall of the second lamellar body is connected with the inwall of the first lamellar body by two connecting portions；First lamellar body includes the first disintegration layer, and the second lamellar body includes being filled with active ingredient particle in the second disintegration layer, the first disintegration layer and the second disintegration layer.The fragrant lotus Orally disintegrating chip architecture of the high effect of reduction by three that the utility model is provided is novel, easy to use, the hollow structure formed in the middle of first lamellar body and the second lamellar body greatly increases the specific surface area of tablet, increase the contact area of tablet and oral environment, so as to be remarkably improved disintegration rate, the dose that single tablet can be carried will not be significantly reduced.First lamellar body and the second lamellar body are segmented into two parts, and user can voluntarily take according to the dosage of doctor's advice, using more flexible and convenient. |
| priorityDate | 2016-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.